Pemetrexed plus platinum as second-line treatment for patients with pleural mesothelioma treated with nivolumab plus ipilimumab

September 15, 2025 | Comments Off on Pemetrexed plus platinum as second-line treatment for patients with pleural mesothelioma treated with nivolumab plus ipilimumab

Lung Cancer 2025 September [Link] Sawana Ono, Hirokazu Taniguchi, Koji Kuroda, Teppei Hashimoto, Asuka Okada, Yasuhiro Goto, Hidenori Kitai, Yoichi Nakamura, Shinsuke Ogusu, Tetsunari Hase, Takayo Ota 10, Noriyuki Ebi,…

Molecular expression of glycosaminoglycans modifies the plasticity of biphasic mesothelioma in favor of tumor progression

September 12, 2025 | Comments Off on Molecular expression of glycosaminoglycans modifies the plasticity of biphasic mesothelioma in favor of tumor progression

Glycoconjugate Journal 2025 August 13 [Link] Camila Machado Baldavira, Aline Nery Qualiotto, Tabatha Gutierrez Prieto, Sandra de Morais Fernezlian, Aline Assato, Marcelo Balancin, Teresa Takagaki, Alexandre Ab’Saber, Ana Paula Pereira…

Co-Targeting Bcl-xL with Mcl-1 Induces Lethal Mitochondrial Dysfunction in Diffuse Mesothelioma

September 11, 2025 | Comments Off on Co-Targeting Bcl-xL with Mcl-1 Induces Lethal Mitochondrial Dysfunction in Diffuse Mesothelioma

Molecular Cancer Therapeutics 2025 August 14 [Link] R Taylor Ripley, Yuan Xu, Cristian G Medina, Deborah R Surman, Lacey E Dobrolecki, Monica Vilchis, Maheshwari Ramineni, Susan G Hilsenbeck, Yanming Li,…

A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value

September 10, 2025 | Comments Off on A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value

Journal of Clinical Medicine 2025 August 4 [Link] Serkan Yaşar, Feride Yılmaz, Ömer Denizhan Tatar, Hasan Çağrı Yıldırım, Zafer Arık 1, Şuayib Yalçın, Mustafa Erman Abstract Background: Pleural mesothelioma (PM)…

Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma

September 9, 2025 | Comments Off on Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma

Oncogenesis 2025 August 11 [Link] Yantang Lin, Christelle Dubey, Tereza Losmanova, Samuel Oevgü Yasmin, Jean-Louis Reymond, Ren-Wang Peng, Haibin Deng, Patrick Dorn, Thomas Michael Marti Abstract Pleural mesothelioma (PM) is…

Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma

September 8, 2025 | Comments Off on Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma

Oncogenesis 2025 August 11 [Link] Yantang Lin, Christelle Dubey, Tereza Losmanova, Samuel Oevgü Yasmin, Jean-Louis Reymond, Ren-Wang Peng, Haibin Deng, Patrick Dorn, Thomas Michael Marti Abstract Pleural mesothelioma (PM) is…

First-line nivolumab plus ipilimumab in pleural mesothelioma: Efficacy and safety data from the real-world MesoNet study

September 5, 2025 | Comments Off on First-line nivolumab plus ipilimumab in pleural mesothelioma: Efficacy and safety data from the real-world MesoNet study

Lung Cancer 2025 August 5 [Link] Rajiv Shah, Eva L Buchmeier, Hans-Georg Kopp, Daniel C Christoph 4, Frank Griesinger, Martin Reck, Petra Hoffknecht, Jonas Kuo, Nikolaj Frost, Christian Grohé, Martin…

Single-cell RNA-sequencing as a potential approach for studying intratumor heterogeneity in pleural mesothelioma

September 4, 2025 | Comments Off on Single-cell RNA-sequencing as a potential approach for studying intratumor heterogeneity in pleural mesothelioma

Lung Cancer 2025 August 5 [Link] Ania Alay, Raúl Marín, Elisabet Aliagas, Mireia Gausachs, Max Ruiz-Gil, Ivan Macia, Amaia Ojanguren, Susana Padrones, Eduard Dorca, Jesús Brenes, Ramón Palmero, Víctor Moreno,…

Prospective Analysis of Mesotheliomas in Subjects with BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease

September 3, 2025 | Comments Off on Prospective Analysis of Mesotheliomas in Subjects with BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease

Journal of Thoracic Oncology 2025 August 5 [Link] Xinwei Wu, Frank-Villa Hernandez, Haitao Wang, Ruihong Wang, Stephanie Shiffka, Niharika Shah, Shamus R Carr, Chuong D Hoang, Andrew M Blakely, Alexandra…

Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses NF2-mutant mesothelioma

September 2, 2025 | Comments Off on Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses NF2-mutant mesothelioma

Life Science Alliance 2025 July 31 [Link] Richard Cunningham, Siyang Jia, Krishna Purohit, Michaela Noskova Fairley 1, Marcin K Maniak, Yue Lin, Ning Sze Hui, Rebecca E Graham, Adriano G…

Categories